A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors
Clinical trial NCT03034304 · TERMINATED
Trial details
- NCT number
- NCT03034304
- Sponsor
- HRYZ Biotech Co.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-22
- Primary completion
- 2023-11-13
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.